LAS VEGAS, NV–(Marketwired – Jun 30, 2015) – After years of exhaustive research and development, the BioAdaptives team (OTCBB: BDPT) is excited to reveal the first five products in our nationwide roll-out, taking place in the third quarter of 2015. These high quality, cutting edge, natural nutraceutical blends use our proprietary process that enhances the
LAS VEGAS, Dec. 7, 2014 /PRNewswire/ — BioAdaptives, Inc. (BDPT) announced results of the recently completed in vivo trial showing the efficacy of its PrimiCell® product on muscle repair. In the study mice were put into groups, PrimiCell® and the control group. The PrimiCell® group was given PrimiCell® for seven days prior to the treatment. Both
LAS VEGAS, Aug. 4, 2014 /PRNewswire via COMTEX/ –– BioAdaptives, Inc. (OTCBB:BDPT) announced results of the clinical trial completed on “PRIMICELL(TM)” which resulted in the research and development of 8 new products. PRIMICELL(TM) is a trademarked name of the first product BioAdaptives, Inc. will bring to market through private labeling and exclusive licensing agreements worldwide. BioAdaptives, Inc. Chairman
LAS VEGAS, July 17, 2014 /PRNewswire via COMTEX/ — BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Dr. Charlie Timmerman, DVM has joined the Advisory Board for its equine products. Dr. Timmerman is a 1970 graduate of University of Georgia. He has practiced in Aiken, South Carolina since graduating and opened the Aiken Veterinary clinic in 1972. BioAdaptives, under
LAS VEGAS, July 14, 2014 /PRNewswire via COMTEX/ — BioAdaptives, Inc. (OTCBB:BDPT) is pleased to announce Mr. Barry Epling, Chairman has assumed the roles of President and CEO of the Company. Mr. Epling is the owner of Ferris Holding, Inc., the company that licensed its formulation, intellectual properties, and other technologies to BioAdaptives, Inc. and its financial supporter. “Mr.
BioAdaptives, Inc. cleared by FINRA for quotation on OTC Bulletin Board and OTC Linkunder the symbol BDPT LAS VEGAS, July 9, 2014 /PRNewswire via COMTEX/ — BioAdaptives, Inc. (OTC BB: BDPT)announced that it is cleared by FINRA for quotation on OTC Bulletin Board and OTC Linkunder the symbol BDPT effective as of July 8, 2014. The company’s market maker is